BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18308103)

  • 1. Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma.
    Magera JS; Leibovich BC; Lohse CM; Sengupta S; Cheville JC; Kwon ED; Blute ML
    Urology; 2008 Feb; 71(2):278-82. PubMed ID: 18308103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
    Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
    Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
    Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
    Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma.
    Choi Y; Park B; Kim K; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee JE; Lee HM
    Br J Cancer; 2013 Feb; 108(2):387-94. PubMed ID: 23299540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma.
    Lee SE; Byun SS; Han JH; Han BK; Hong SK
    BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.
    Frank I; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Dec; 168(6):2395-400. PubMed ID: 12441925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy.
    Życzkowski M; Kaletka Z; Rajwa P; Rempega G; Stelmach P; Bogacki R; Łach-Wojnarowicz O; Paradysz E
    Int Urol Nephrol; 2020 May; 52(5):885-891. PubMed ID: 31953718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma.
    Michigan A; Johnson TV; Master VA
    Mol Diagn Ther; 2011 Aug; 15(4):229-34. PubMed ID: 21756006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.
    Webster WS; Thompson RH; Cheville JC; Lohse CM; Blute ML; Leibovich BC
    Urology; 2007 Nov; 70(5):900-4; discussion 904. PubMed ID: 18068445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.
    Zhang Y; Yu H; Li H
    Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
    Cheville JC; Lohse CM; Zincke H; Weaver AL; Leibovich BC; Frank I; Blute ML
    Am J Surg Pathol; 2004 Apr; 28(4):435-41. PubMed ID: 15087662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
    Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
    Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
    Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
    Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP; Lohse CM; Zaid HB; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.